Cargando…
Alu hypomethylation and MGMT hypermethylation in serum as biomarkers of glioma
In order to improve prognosis of glioma patients, better tools are required for early diagnosis and treatment. Serum cell-free DNA methylation levels of Alu, MGMT, P16, RASSF1A from 124 glioma patients and 58 healthy controls were detected by the bisulfite sequencing. The median methylation level of...
Autores principales: | Gong, Mingjie, Shi, Wei, Qi, Jing, Shao, Guoping, Shi, Zhenghua, Wang, Junxiang, Chen, Jian, Chu, Rongtao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652743/ https://www.ncbi.nlm.nih.gov/pubmed/29100349 http://dx.doi.org/10.18632/oncotarget.20012 |
Ejemplares similares
-
Concurrent hypermethylation of DNMT1, MGMT and EGFR genes in progression of gliomas
por: Gömöri, Éva, et al.
Publicado: (2012) -
LINE-1 and Alu hypomethylation in mucoepidermoid carcinoma
por: Sirivanichsuntorn, Porntipa, et al.
Publicado: (2013) -
The association between Alu hypomethylation and the severity of hypertension
por: Thongsroy, Jirapan, et al.
Publicado: (2022) -
Alu methylation serves as a biomarker for non-invasive diagnosis of glioma
por: Chen, Jian, et al.
Publicado: (2016) -
Hypomethylation of Alu Elements in Post-Menopausal Women with Osteoporosis
por: Jintaridth, Pornrutsami, et al.
Publicado: (2013)